Synokem Lifesciences Private Limited

Synokem Lifesciences Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24230DL2020PTC362777 Incorporated 14 March 2020 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma
Revenue · FY 2025
₹99.46 Cr
▲ 108% YoY
Net loss · FY 2025
₹29.55 Cr
Net margin -29.7%
EBITDA · FY 2025
-₹9.68 Cr
EBITDA margin -9.7%
Authorised capital
₹180 Cr
Registered with MCA
Paid-up capital
₹175.25 Cr
Issued & subscribed
Open charges
₹115 Cr
Satisfied ₹19 Cr
Company age
6 yrs
Est. 2020
Employees · EPFO
401
Provident fund records

About Synokem Lifesciences Private Limited

Data last updated:

Synokem Lifesciences Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Synokem Pharmaceuticals Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 March 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2020PTC362777. Its GSTIN is 07ABDCS5598N1ZH (Delhi). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹180 Cr and a paid-up capital of ₹175.25 Cr. It is led by directors including Abhinav Arora (Managing Director) and Thomas Baby.

Its last annual general meeting (AGM) was held on 08 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Block – A 14/486 Ground Floor, Outer Ring Road Paschim Vihar, New Delhi, Delhi, India – 110087.

As per the financials filed for FY 2025, the company reported a revenue of ₹99.46 Cr, a growth of 108% compared to the previous year. For the same year it recorded a net loss of ₹29.55 Cr (net margin -29.7%) and EBITDA of -₹9.68 Cr (EBITDA margin -9.7%). Revenue has grown at a compounded annual rate (CAGR) of 664% over three years.

The company has about 401 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹115 Cr and satisfied charges of ₹19 Cr on record. The company has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in September 2020. Its 6 peer companies in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Credo Life Sciences Private Limited with revenue of ₹100.47 Cr. The company has 4 MSME Form 1 returns on record between 2023 and 2024, listing 535 overdue payments to 105 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website synokempharma.com.

Company details

CIN U24230DL2020PTC362777
Registration Number 362777
Incorporation Date 14 March 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Parent Company Synokem Pharmaceuticals Limited
Compliance Status Active Compliant

Contact details

Synokem Lifesciences Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Block – A 14/486 Ground Floor, Outer Ring Road Paschim Vihar, New Delhi, Delhi, India – 110087
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Synokem Lifesciences Private Limited, buy the company report.

Comprehensive company report
Synokem Lifesciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Synokem Lifesciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Synokem Lifesciences Private Limited, buy the company report.

Financials of Synokem Lifesciences Private Limited

FY 2025 filings available

Synokem Lifesciences Private Limited reported revenue of ₹99.46 Cr (up 108% YoY) for FY 2025.

Revenue · FY 2025
₹99.46 Cr ▲ 108%
Net loss · FY 2025
₹29.55 Cr margin -29.7%
EBITDA · FY 2025
-₹9.68 Cr margin -9.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 108%
3 years · compounded
▲ 664%
EBITDA CAGR growth
1 year
▲ 20%
3 years · compounded
▼ 197%

Revenue has grown at a compounded annual rate (CAGR) of 664% over three years, including 108% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹9.68 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹29.55 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-9.7%
Net Profit Margin-29.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Synokem Lifesciences Private Limited, buy the company report.

Board of directors of Synokem Lifesciences Private Limited

Synokem Lifesciences has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Abhinav AroraManaging Director14 Mar 20206 Years 8 MonthsCurrent
Thomas BabyDirector03 May 20224 Years 6 MonthsCurrent
Vishal GuptaNominee Director18 Jan 20233 Years 10 MonthsCurrent
Shubhangi AgarwalDirector27 Nov 20250 Years 11 MonthsCurrent

Peer comparison

Synokem Lifesciences Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Credo Life Sciences Private Limited₹100.47 Cr (FY 2024)22.0%Hyderabad, Telangana, India
Consern Pharma Limited₹100.37 Cr (FY 2025)-2.0%Ludhiana, Punjab, India
Medibios Laboratories Limited₹100.12 Cr (FY 2023)-2.0%
Synokem Lifesciences Private Limitedthis company₹99.46 Cr (FY 2025)-₹29.55 Cr-29.7%108.0%401New Delhi, Delhi, India
Claroid Pharmaceuticals Limited₹98.31 Cr (FY 2025)48.0%Ahmedabad, Gujarat, India
Sirmour Remedies Private Limited₹98.1 Cr (FY 2025)-18.0%Paonta Sahib, Himachal Pradesh, India
Enicar Pharmaceuticals Private Limited₹97.81 Cr (FY 2025)-1.0%Boisar, Maharashtra, India

To see the full peer comparison of Synokem Lifesciences Private Limited, buy the company report.

Auditor

Synokem Lifesciences Private Limited is audited by BSR & Co. LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
BSR & Co. LLPFY 2023101248W/W-100022

Shareholding

The shareholding of Synokem Lifesciences Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Synokem Lifesciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹115 Cr
Satisfied charges
₹19 Cr
Breakdown by lending institutions
Others₹115.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
22 Sep 2023100791388Others₹115 CrOpen
28 Apr 2022100573857Others₹19 CrSatisfied

To see the full charge records of Synokem Lifesciences Private Limited, buy the company report.

Total charge records: 2 View all charges

Deals & funding

Synokem Lifesciences Private Limited has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in September 2020.

Total deals
2
Rights issue
1
Secondary share transfer
1

Deals on record (2 of 2)

WhenDealAmountParties
Sep 2020Rights issue₹44.99 CrInvestors: Synokem Pharmaceuticals Limited
Aug 2020Secondary share transferUndisclosedBuyer: Synokem Pharmaceuticals Limited , Synokem Pharmaceuticals Limited & Abhinav Arora
Seller: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Synokem Lifesciences Private Limited has 4 MSME Form 1 returns on record between 2023 and 2024, listing 535 overdue payments to 105 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 105)

SupplierAmount dueDue sinceReported on
Trichem Lifesciences Limited
Panvo Organics Private Limited
Abs Packaging Industries
Shiva Printing and Packaging
SPL Packaging LLP

To see the full MSME payment records of Synokem Lifesciences Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Synokem Lifesciences Private Limited has a workforce of 401 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
401
Active EPFO establishments
1
Employee growth
14.2%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27401
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23

To see the full employee and EPFO history of Synokem Lifesciences Private Limited, buy the company report.

GST

Synokem Lifesciences has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
07ABDCS5598N1ZHDelhiActive18 Jun 2020
05ABDCS5598N1ZLUttarakhandActive27 Dec 2020

To see the full GST registrations and return filing status of Synokem Lifesciences Private Limited, buy the company report.

Recent activity

Synokem Lifesciences Private Limited has 6 board changes on record since 2020: 5 appointments and 1 cessation. The latest: Shubhangi Agarwal was appointed as Director on 27 Nov 2025.

Appointed
Shubhangi Agarwal was appointed as Director.
AGM
Synokem Lifesciences Private Limited last Annual general meeting of members was held on 08 Sep 2025 as per latest MCA records.
Filing
Synokem Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Abhiruchi Arora ceased to be Director.
Charges
A charge with Others of Rs. 115.00 Cr registered on 22 Sep 2023 with Charge ID 100791388 was modified on 24 Jan 2024.
Charges
A charge registered on 28 Apr 2022 via Charge ID 100573857 with Others was fully satisfied on 21 Nov 2023.
Charges
A charge with Others amounted to Rs. 115.00 Cr with Charge ID 100791388 was registered on 22 Sep 2023.
Appointed
Vishal Gupta was appointed as Nominee Director.
Appointed
Thomas Baby was appointed as Director.
Charges
A charge with Others amounted to Rs. 19.00 Cr with Charge ID 100573857 was registered on 28 Apr 2022.
Appointed
Abhinav Arora was appointed as Managing Director.
Appointed
Abhiruchi Arora was appointed as Director.

1 earlier event is in the company report.

Frequently asked questions

Synokem Lifesciences is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 March 2020 (6+ years old) and is registered under CIN U24230DL2020PTC362777.

Synokem Lifesciences has 4 current directors:

The latest financial statements of Synokem Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 08 September 2025. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Synokem Lifesciences is 07ABDCS5598N1ZH, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 05ABDCS5598N1ZL (Uttarakhand).

The CIN (Corporate Identification Number) of Synokem Lifesciences is U24230DL2020PTC362777. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Synokem Lifesciences was incorporated on 14 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.

Synokem Lifesciences has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in September 2020.

The peers of Synokem Lifesciences by revenue are Credo Life Sciences Private Limited, Consern Pharma Limited, Medibios Laboratories Limited, Claroid Pharmaceuticals Limited, Sirmour Remedies Private Limited and 1 more, all in the Pharma industry (Formulations, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Shubhangi Agarwal was appointed as Director on 27 Nov 2025. Abhiruchi Arora ceased to be Director on 01 Feb 2024. Vishal Gupta was appointed as Nominee Director on 18 Jan 2023. Synokem Lifesciences has 6 board changes on record in total.

Synokem Lifesciences has 4 MSME Form 1 returns on record between 2023 and 2024, listing 535 overdue payments to 105 micro and small suppliers. The latest return was filed on 13 May 2024.

Synokem Lifesciences can be reached through the website synokempharma.com. Its registered office is in New Delhi, Delhi, India.

The registered office of Synokem Lifesciences is at Block – A 14486 Ground Floor, Outer Ring Road Paschim Vihar, New Delhi, Delhi, India – 110087.